glp 1 drugs in india India's GLP-1 Adoption Lags Despite Cheaper Prices | Nithin Kamath posted on the topic India issues strict guidelines limiting
Description
Belli M, Barone L, Bellia A, et al
bit.ly/JASN0477 @LParkerGregg1 @MichaelEMatheny Little is known about the association of discontinuation of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) with outcomes in patients with CKD
Double diabeteswhen type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition
doi: 10.1111/j.2040-1124.2010.00022.x [DOI] [PMC free article] [PubMed] [Google Scholar] 125
Abstract This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity
These side effects mostly show up in the digestive system
